Polyarteritis nodosa. Differential diagnostics and therapy

被引:0
|
作者
Schirmer, J. H. [1 ,2 ]
Holl-Ulrich, K. [3 ]
Moosig, F. [1 ,2 ]
机构
[1] Univ Klinikum Schleswig Holstein, Klin Rheumatol & Immunol, Bad Bramstedt, Germany
[2] Vaskulitisklin, Bad Bramstedt, Germany
[3] Univ Klinikum Schleswig Holstein, Referenzzentrum Vaskulitisdiagnost, Inst Pathol, Bad Bramstedt, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2014年 / 73卷 / 10期
关键词
Polyarteritis nodosa; Vasculitis; Hepatitis B; Immunosuppressants; Arteries; CHURG-STRAUSS-SYNDROME; POOR-PROGNOSIS FACTORS; HEPATITIS-B-VIRUS; MICROSCOPIC POLYANGIITIS; SYSTEMIC VASCULITIDES; CONSENSUS CONFERENCE; VESSEL VASCULITIS; RANDOMIZED-TRIAL; NOMENCLATURE; CRITERIA;
D O I
10.1007/s00393-014-1483-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polyarteritis nodosa (PAN) is a necrotizing vasculitis of medium size arteries that may affect various organs. The clinical appearance is very variable. The most common manifestations are of the skin, the peripheral nervous system presenting as mononeuritis multiplex and the mesenteric and renal blood vessels due to the development of stenoses and small aneurysms. Of the cases one third are estimated to be associated with hepatitis B virus (HBV). The therapy depends on the pathogenesis of the disease: primary PAN is treated with immunosuppressants, whereas patients with HBV-related PAN should receive antiviral therapy and plasmapheresis. Differentiating PAN from other forms of vasculitis can be difficult and requires complex differential diagnostics.
引用
收藏
页码:917 / 926
页数:10
相关论文
共 50 条
  • [31] The challenge of managing patients with polyarteritis nodosa
    Segelmark, Marten
    Selga, Daina
    CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (01) : 33 - 38
  • [32] Cutaneous polyarteritis nodosa
    Diaz-Perez, Jose L.
    De Lagran, Zurine Martinez
    Diaz-Ramon, Jose Luis
    Winkelmann, Richard K.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2007, 26 (02) : 77 - 86
  • [33] Abdominal polyarteritis nodosa:: angiographic features
    Mnif, N
    Chaker, M
    Oueslati, S
    Ellouze, T
    Tenzakhti, F
    Turki, S
    Ben Abdallah, N
    Ben Maïz, H
    Hamza, R
    JOURNAL DE RADIOLOGIE, 2004, 85 (05): : 635 - 638
  • [34] Infliximab for the treatment of refractory polyarteritis nodosa
    Ginsberg, Shira
    Rosner, Itzhak
    Slobodin, Gleb
    Rozenbaum, Michael
    Kaly, Lisa
    Jiries, Nizar
    Boulman, Nina
    Awisat, Abid
    Hussein, Haya
    Novofastovski, Irina
    Silawy, Amal
    Rimar, Doron
    CLINICAL RHEUMATOLOGY, 2019, 38 (10) : 2825 - 2833
  • [35] Muscular Polyarteritis Nodosa
    Yang, Seung Nam
    Cho, Nam Soon
    Choi, Hyun Soo
    Choi, Seong Jae
    Yoon, Eul-Sik
    Kim, Dong Hwee
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2012, 18 (05) : 249 - 252
  • [36] Polyarteritis nodosa and deficiency of adenosine deaminase 2-Shared genealogy, generations apart
    Huang, Zhengping
    Li, Tianwang
    Nigrovic, Peter A.
    Lee, Pui Y.
    CLINICAL IMMUNOLOGY, 2020, 215
  • [37] Hypertension in the liver clinic - polyarteritis nodosa in a patient with hepatitis B
    Laroia, Shalini Thapar
    Lata, Suman
    WORLD JOURNAL OF CLINICAL CASES, 2016, 4 (03) : 94 - 98
  • [38] Overlap between systemic sclerosis and polyarteritis nodosa: A case report
    Mahmoud, Geilan A.
    Elsaid, Nora Y.
    Zayed, Hania S.
    EGYPTIAN RHEUMATOLOGIST, 2021, 43 (04) : 353 - 356
  • [39] Deficiency of adenosine deaminase 2: a challenging differential diagnosis of polyarteritis nodosa
    Hassanzadeh, Shakiba
    Bahadoram, Mohammad
    Mowla, Karim
    REUMATOLOGIA, 2023, 61 (01): : 45 - 54
  • [40] Polyarteritis Nodosa: Old Disease, New Etiologies
    Wolff, Louis
    Horisberger, Alice
    Moi, Laura
    Karampetsou, Maria P.
    Comte, Denis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)